NTHL1 and breast carcinoma: No additional bi-allelic LoF variants were identified in subjects of the validation dataset, indicating germline bi-allelic loss of NTHL1 is extremely rare as a cause of breast cancer (1/27,421 breast cancer cases and 0/19,759 controls).